Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Actinium starts dosing second cohort in trial of Actimab-A and CLAG-M

Myeloblasts with Auer rods seen in acute myeloid leukemia. Credit: Paulo Henrique OrlandiMourao.

  • Actinium

Go Top